Delveinsight

AUGUST 2, 2021

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. Historically, the gold standard of the treatment for Peanut allergy constituted a strategic plan for peanut avoidance coupled with an adrenaline auto-injector (AAI) in case of contingencies.

Allergies 97

Allergies Marketing Development Trials 97

Medical Xpress

FEBRUARY 28, 2023

A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

Allergies 75

Allergies Clinical Trials Clinical Trials Medicine 75

Drug Discovery World

OCTOBER 13, 2022

New research has shown that standard cat allergy treatment can be enhanced to make it more effective and faster acting, and the benefits last for a year after treatment ends. The findings of the study, supported by the National Institutes of Health, were published in the Journal of Allergy and Clinical Immunology. .

Allergies 52

Allergies Gene Antibody Trials 52

STAT News

JANUARY 18, 2023

The National Institute of Allergy and Infectious Diseases reported Wednesday that a Phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. Yet another experimental HIV vaccine has failed. The vaccine was being developed by Janssen, the vaccine division of Johnson & Johnson.

Clinical Trials 145

Clinical Trials Clinical Trials Vaccination Vaccine 145

Scienmag

JANUARY 20, 2022

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

Allergies 89

Allergies Trial Funding Clinical Trials Clinical Trials 89

BioTech 365

OCTOBER 29, 2021

Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Peanut Allergy – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s (..)

Allergies 40

Allergies Clinical Trials Clinical Trials Trials 40

Rethinking Clinical Trials

NOVEMBER 29, 2022

The NIH Pragmatic Trials Collaboratory is excited to welcome the INSPIRE Demonstration Project to its portfolio of innovative, large-scale pragmatic clinical trials embedded in healthcare systems. Although fewer than 5% of such patients have an antibiotic-resistant infection, more than half receive extended-spectrum antibiotics.

Trials 130

Trials Clinical Trials Clinical Trials Allergies 130

pharmaphorum

DECEMBER 10, 2020

Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Allergies 103

Allergies Vaccination Vaccine Regulation 103

Pharma Mirror

DECEMBER 1, 2021

Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The post Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 appeared first on Pharma Mirror Magazine.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Antidote

SEPTEMBER 1, 2023

As part of our efforts to better understand patients and their motivations to participate in clinical trials, Antidote and SCORR Marketing partnered on a survey to gain a deeper understanding of how patients think about the medical research process.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Allergies 95

Pharma Times

FEBRUARY 10, 2021

Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)

Trials 147

Trials Allergies 147

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. In this blog post, we’ll explore the top ten benefits of clinical trial home visits to help you make an informed decision about whether or not this type of service is right for your study.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. In this blog post, we’ll explore the top ten benefits of clinical trial home visits to help you make an informed decision about whether or not this type of service is right for your study.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. In this blog post, we’ll explore the top ten benefits of clinical trial home visits to help you make an informed decision about whether or not this type of service is right for your study.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. In this blog post, we’ll explore the top ten benefits of clinical trial home visits to help you make an informed decision about whether or not this type of service is right for your study.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Druggist

APRIL 20, 2021

Today I will explore a different use of montelukast and answer the main question: can you use montelukast for allergies? Can you use montelukast for allergies? Can you use montelukast for allergies? Use of montelukast for allergies: what is the evidence? . Summary: What is montelukast. Licensed use of montelukast.

Allergies 52

Allergies Licensing Licensing Drugs 52

Medical Xpress

JANUARY 17, 2023

A promising approach to control Staphylococcus aureus bacterial colonization in people—using a probiotic instead of antibiotics—was safe and highly effective in a Phase 2 clinical trial. aureus colonization in trial participants without harming the gut microbiota, which includes bacteria that can benefit people.

Trials 81

Trials Allergies Bacteria Clinical Trials 81

The Pharma Data

JANUARY 7, 2021

This clearance is a pivotal regulatory milestone that further supports Camallergy’s leadership and capabilities in the field of peanut allergy immunotherapy with the only cGMP-certified manufacturing facility in Europe producing peanut oral immunotherapy,” said Sherden Timmins, Chief Technology Officer. 8, 2021 07:00 UTC. About Camallergy.

Allergies 52

Allergies Manufacturing Production Clinical Trials 52

pharmaphorum

AUGUST 5, 2020

DBV Technologies’ long and tortuous path to an FDA verdict on its Viaskin Peanut allergy shot has led to another dead end. DBV says it plans to request a meeting with the FDA to discuss its comments in the CRL as well, as that may be needed in another clinical trial to support another refiling. “We

Allergies 52

Allergies Production Clinical Trials Clinical Trials 52

DM Clinical Research

APRIL 30, 2021

And while this means that most of us can get outside and enjoy the nice weather, it means something different to allergy sufferers. If you have seasonal allergies, then you know how painful and annoying your symptoms can be. Certain symptoms might have you wondering- is it allergies or COVID? Is it Allergies or COVID symptoms?

Allergies 40

Allergies Clinical Research Vaccination Vaccine 40

Medical Xpress

MARCH 6, 2023

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. A non-temperature stable form of the candidate previously had been tested in several clinical trials.

Immune Response 75

Immune Response Vaccination Vaccine Trials 75

Antidote

NOVEMBER 20, 2023

In both 2018 and 2023, Antidote partnered with SCORR marketing to conduct surveys intended to increase the understanding of patients’ perceptions of clinical trials. Our 2018 survey collected data from nearly 4,000 individuals to gain insight into what matters most when considering a clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Allergies 52

Scienmag

NOVEMBER 18, 2021

Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can […].

Clinical Trials 86

Clinical Trials Clinical Trials Trial Funding Trials 86

Scienmag

APRIL 21, 2021

Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

Antibody 81

Antibody Clinical Trials Clinical Trials Trials 81

Drug Discovery World

SEPTEMBER 25, 2023

Enrolment in a Phase I trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland, US. With each new universal influenza vaccine candidate and clinical trial, we take another step closer to that goal,” said Acting NIAID Director Hugh Auchincloss.

Vaccination 52

Vaccination Vaccine Trials Immune Response 52

Medical Xpress

MARCH 2, 2023

Allergic reactions to the Pfizer or Moderna COVID vaccines are very rare, and a new study questions whether many of those that do occur are even real.

Allergies 66

Allergies Vaccination Vaccine Trials 66

Drug Discovery World

NOVEMBER 29, 2023

At sites in the US, Japan, and the EU, the clinical trial will evaluate the safety, tolerability, and efficacy of leniolisib in 15 children, one to six years of age, who have a confirmed APDS diagnosis. The post Trials investigate targeted APDS treatment in a paediatric setting appeared first on Drug Discovery World (DDW).

Trials 52

Trials Clinical Trials Clinical Trials Allergies 52

Delveinsight

AUGUST 6, 2020

Zydus starts phase 2 COVID-19 vaccine trial after clearing safety test. Zydus Cadila has finished a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 study. Zydus has only said that the vaccine was well tolerated by people who received it in the first phase of the trial.

Allergies 53

Allergies Vaccination Vaccine Gene Therapy 53

Rethinking Clinical Trials

JANUARY 24, 2023

The trial is comparing routine care under hospital-based antibiotic stewardship programs with an enhanced program that adds a predictive algorithm to reduce unnecessary prescribing of extended-spectrum antibiotics.

Allergies 130

Allergies Clinical Trials Clinical Trials Trials 130

Clinical Trial Podcast

SEPTEMBER 26, 2022

To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials. The post Complexity in Early Phase Clinical Trials with Dr. Oren Cohen? The post Complexity in Early Phase Clinical Trials with Dr. Oren Cohen?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

Drug Discovery World

MAY 17, 2023

A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults.

Contamination 52

Contamination Trials Drugs Allergies 52

Medical Xpress

DECEMBER 22, 2022

The study analyzed data from two phase 3 clinical trials and involved an international group of researchers, including those from Children's Hospital of Philadelphia (CHOP).

Antibody 75

Antibody Allergies Clinical Trials Clinical Trials 75

STAT News

SEPTEMBER 12, 2022

National Institutes of Health is launching a Phase 3 clinical trial to determine the efficacy of tecovirimat — the smallpox antiviral better known as TPOXX — for use in treating monkeypox, as current data on its effectiveness against the virus is limited , The Hill writes. The TPOXX was approved by the U.S.

FDA Approval 98

FDA Approval Trials Clinical Trials Clinical Trials 98

BioSpace

APRIL 26, 2021

Top-line results from the Phase III INVIGORATE trial show Aldeyra Therapeutics’, reproxalap, significantly reduced ocular itching in patients with allergic conjunctivitis.

Allergies 74

Allergies Trials 74

Drug Discovery World

MAY 18, 2023

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) has begun enrolling volunteers at Duke University in Durham, North Carolina. The trial will enrol up to 50 healthy volunteers aged 18 to 49.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

pharmaphorum

FEBRUARY 18, 2022

Sanofi and Regeneron have reported disappointing results in a trial of Dupixent in people with chronic spontaneous urticaria (CSU) who don’t respond to the only approved biologic treatment, Novartis/Roche’s Xolair. . The post Dupixent falls short in phase 3 chronic spontaneous urticaria trial appeared first on.

Trials 105

Trials Sales Allergies Drugs 105

The Pharma Data

OCTOBER 27, 2020

The NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has halted a clinical trial evaluating Eli Lilly’s investigational monoclonal antibody, LY-CoV555 (bamlanivimab), in combination with remdesivir for the treatment of COVID-19 patients. Source link.

Antibody 52

Antibody Trials Allergies Clinical Trials 52